DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Fiedler VB, Perzborn E, Seuter F, Rosentreter U, Boshagen H.
Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-Fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid.
Arzneim Forsch Drug Res 1989;
39: 1527-30
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.